DAIHAN Scientific Statistics
Total Valuation
DAIHAN Scientific has a market cap or net worth of KRW 34.02 billion. The enterprise value is 37.93 billion.
Market Cap | 34.02B |
Enterprise Value | 37.93B |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
DAIHAN Scientific has 7.45 million shares outstanding. The number of shares has decreased by -1.55% in one year.
Current Share Class | n/a |
Shares Outstanding | 7.45M |
Shares Change (YoY) | -1.55% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 44.11% |
Owned by Institutions (%) | n/a |
Float | 3.57M |
Valuation Ratios
The trailing PE ratio is 16.03.
PE Ratio | 16.03 |
Forward PE | n/a |
PS Ratio | 0.45 |
PB Ratio | 0.85 |
P/TBV Ratio | 0.85 |
P/FCF Ratio | 17.44 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.61, with an EV/FCF ratio of 19.45.
EV / Earnings | 19.02 |
EV / Sales | 0.54 |
EV / EBITDA | 6.61 |
EV / EBIT | 9.73 |
EV / FCF | 19.45 |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.04.
Current Ratio | 3.79 |
Quick Ratio | 1.33 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.39 |
Debt / FCF | 1.13 |
Interest Coverage | 25.65 |
Financial Efficiency
Return on equity (ROE) is 6.44% and return on invested capital (ROIC) is 4.65%.
Return on Equity (ROE) | 6.44% |
Return on Assets (ROA) | 3.87% |
Return on Capital (ROIC) | 4.65% |
Revenue Per Employee | 619.85M |
Profits Per Employee | 17.49M |
Employee Count | 114 |
Asset Turnover | 1.13 |
Inventory Turnover | 1.97 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.55% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -24.55% |
50-Day Moving Average | 4,680.70 |
200-Day Moving Average | 5,339.75 |
Relative Strength Index (RSI) | 46.65 |
Average Volume (20 Days) | 23,653 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DAIHAN Scientific had revenue of KRW 70.66 billion and earned 1.99 billion in profits. Earnings per share was 284.75.
Revenue | 70.66B |
Gross Profit | 20.00B |
Operating Income | 3.88B |
Pretax Income | 4.12B |
Net Income | 1.99B |
EBITDA | 5.72B |
EBIT | 3.88B |
Earnings Per Share (EPS) | 284.75 |
Balance Sheet
The company has 8.75 billion in cash and 2.20 billion in debt, giving a net cash position of 6.55 billion or 878.42 per share.
Cash & Cash Equivalents | 8.75B |
Total Debt | 2.20B |
Net Cash | 6.55B |
Net Cash Per Share | 878.42 |
Equity (Book Value) | 50.54B |
Book Value Per Share | 5,378.26 |
Working Capital | 32.32B |
Cash Flow
In the last 12 months, operating cash flow was 2.44 billion and capital expenditures -492.11 million, giving a free cash flow of 1.95 billion.
Operating Cash Flow | 2.44B |
Capital Expenditures | -492.11M |
Free Cash Flow | 1.95B |
FCF Per Share | 261.71 |
Margins
Gross margin is 28.30%, with operating and profit margins of 5.49% and 2.82%.
Gross Margin | 28.30% |
Operating Margin | 5.49% |
Pretax Margin | 5.83% |
Profit Margin | 2.82% |
EBITDA Margin | 8.09% |
EBIT Margin | 5.49% |
FCF Margin | 2.76% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 1.31%.
Dividend Per Share | 60.00 |
Dividend Yield | 1.31% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 32.52% |
Buyback Yield | 1.55% |
Shareholder Yield | 2.86% |
Earnings Yield | 6.24% |
FCF Yield | 5.73% |
Stock Splits
The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.07.
Last Split Date | Dec 29, 2014 |
Split Type | Forward |
Split Ratio | 1.07 |
Scores
DAIHAN Scientific has an Altman Z-Score of 4.65.
Altman Z-Score | 4.65 |
Piotroski F-Score | n/a |